miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan

Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs

(2016) Jin Zhang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

(2016) Naomi B Haas et al.   LANCET

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

(2016) Andrew J Armstrong et al.   LANCET ONCOLOGY

Emerging therapies: angiogenesis inhibitors for ovarian cancer

(2015) Amanda L Jackson et al.   EXPERT OPINION ON EMERGING DRUGS

Serum microRNA-205 as a novel biomarker for cervical cancer patients

(2014) Quanhui Ma et al.   Cancer Cell International

Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells

(2013) C. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation

(2012) Shanna A. Arnold et al.   PLoS One

miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells

(2012) Hong Xie et al.   PLoS One

miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines

(2011) H. Chai et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Role of the Renin-Angiotensin System in Gynecologic Cancers

(2011) K. Ino et al.   CURRENT CANCER DRUG TARGETS

Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer

(2011) Chang Gong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population

(2010) Jing Dong et al.   CARCINOGENESIS

VEGF Hypersecretion as a Plausible Mechanism for Pseudo-Meigs' Syndrome in Advanced Colorectal Cancer

(2010) Y. Okuchi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

microRNA-205 Regulates HER3 in Human Breast Cancer

(2009) M. V. Iorio et al.   CANCER RESEARCH

miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C 

(2009) P. Gandellini et al.   CANCER RESEARCH

Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells

(2009) Nalinie S. Wickramasinghe et al.   NUCLEIC ACIDS RESEARCH

MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells

(2008) T. Papagiannakopoulos et al.   CANCER RESEARCH

Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome

(2008) Y. Xue et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA